Annual EBIT
-$126.04 M
-$32.62 M-34.92%
December 31, 2023
Summary
- As of February 8, 2025, VOR annual earnings before interest & taxes is -$126.04 million, with the most recent change of -$32.62 million (-34.92%) on December 31, 2023.
- During the last 3 years, VOR annual EBIT has fallen by -$82.67 million (-190.63%).
- VOR annual EBIT is now -3902.41% below its all-time high of -$3.15 million, reached on December 31, 2018.
Performance
VOR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$28.51 M
+$522.00 K+1.80%
September 30, 2024
Summary
- As of February 8, 2025, VOR quarterly earnings before interest & taxes is -$28.51 million, with the most recent change of +$522.00 thousand (+1.80%) on September 30, 2024.
- Over the past year, VOR quarterly EBIT has dropped by -$389.00 thousand (-1.38%).
- VOR quarterly EBIT is now -632.42% below its all-time high of -$3.89 million, reached on December 31, 2019.
Performance
VOR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$118.00 M
+$6.80 M+5.45%
September 30, 2024
Summary
- As of February 8, 2025, VOR TTM earnings before interest & taxes is -$118.00 million, with the most recent change of +$6.80 million (+5.45%) on September 30, 2024.
- Over the past year, VOR TTM EBIT has increased by +$8.04 million (+6.38%).
- VOR TTM EBIT is now -2931.03% below its all-time high of -$3.89 million, reached on December 31, 2019.
Performance
VOR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VOR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.9% | -1.4% | +6.4% |
| 3 y3 years | -190.6% | -1.4% | +6.4% |
| 5 y5 years | -3902.4% | -1.4% | +6.4% |
VOR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -82.6% | at low | -55.8% | +19.3% | -71.0% | +7.8% |
| 5 y | 5-year | -1131.9% | at low | -632.4% | +19.3% | -2931.0% | +7.8% |
| alltime | all time | -3902.4% | at low | -632.4% | +19.3% | -2931.0% | +7.8% |
Vor Biopharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$28.51 M(-1.8%) | -$118.00 M(-5.5%) |
| Jun 2024 | - | -$29.04 M(-10.2%) | -$124.80 M(-2.5%) |
| Mar 2024 | - | -$32.33 M(+14.9%) | -$127.94 M(+1.5%) |
| Dec 2023 | -$126.04 M(+34.9%) | -$28.12 M(-20.4%) | -$126.04 M(+2.8%) |
| Sep 2023 | - | -$35.32 M(+9.8%) | -$122.64 M(+10.1%) |
| Jun 2023 | - | -$32.17 M(+5.8%) | -$111.42 M(+10.3%) |
| Mar 2023 | - | -$30.42 M(+23.0%) | -$101.04 M(+8.2%) |
| Dec 2022 | -$93.42 M | -$24.73 M(+2.6%) | -$93.42 M(+7.4%) |
| Sep 2022 | - | -$24.10 M(+10.6%) | -$87.00 M(+6.7%) |
| Jun 2022 | - | -$21.79 M(-4.4%) | -$81.50 M(+4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$22.80 M(+24.5%) | -$78.09 M(+13.1%) |
| Dec 2021 | -$69.02 M(+59.2%) | -$18.31 M(-1.6%) | -$69.02 M(+4.0%) |
| Sep 2021 | - | -$18.60 M(+1.2%) | -$66.38 M(+11.4%) |
| Jun 2021 | - | -$18.38 M(+33.9%) | -$59.56 M(+21.0%) |
| Mar 2021 | - | -$13.73 M(-12.3%) | -$49.22 M(+13.5%) |
| Dec 2020 | -$43.37 M(+323.9%) | -$15.66 M(+32.9%) | -$43.37 M(+37.3%) |
| Sep 2020 | - | -$11.79 M(+46.6%) | -$31.60 M(+59.5%) |
| Jun 2020 | - | -$8.04 M(+2.1%) | -$19.81 M(+68.3%) |
| Mar 2020 | - | -$7.88 M(+102.4%) | -$11.77 M(+202.4%) |
| Dec 2019 | -$10.23 M(+224.9%) | -$3.89 M | -$3.89 M |
| Dec 2018 | -$3.15 M | - | - |
FAQ
- What is Vor Biopharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Vor Biopharma?
- What is Vor Biopharma annual EBIT year-on-year change?
- What is Vor Biopharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Vor Biopharma?
- What is Vor Biopharma quarterly EBIT year-on-year change?
- What is Vor Biopharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Vor Biopharma?
- What is Vor Biopharma TTM EBIT year-on-year change?
What is Vor Biopharma annual earnings before interest & taxes?
The current annual EBIT of VOR is -$126.04 M
What is the all time high annual EBIT for Vor Biopharma?
Vor Biopharma all-time high annual earnings before interest & taxes is -$3.15 M
What is Vor Biopharma annual EBIT year-on-year change?
Over the past year, VOR annual earnings before interest & taxes has changed by -$32.62 M (-34.92%)
What is Vor Biopharma quarterly earnings before interest & taxes?
The current quarterly EBIT of VOR is -$28.51 M
What is the all time high quarterly EBIT for Vor Biopharma?
Vor Biopharma all-time high quarterly earnings before interest & taxes is -$3.89 M
What is Vor Biopharma quarterly EBIT year-on-year change?
Over the past year, VOR quarterly earnings before interest & taxes has changed by -$389.00 K (-1.38%)
What is Vor Biopharma TTM earnings before interest & taxes?
The current TTM EBIT of VOR is -$118.00 M
What is the all time high TTM EBIT for Vor Biopharma?
Vor Biopharma all-time high TTM earnings before interest & taxes is -$3.89 M
What is Vor Biopharma TTM EBIT year-on-year change?
Over the past year, VOR TTM earnings before interest & taxes has changed by +$8.04 M (+6.38%)